These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2507222)

  • 1. In vitro activity of lomefloxacin against Chlamydia trachomatis, Neisseria gonorrhoeae, Haemophilus ducreyi, Mycoplasma hominis, and Ureaplasma urealyticum.
    Hoban D; DeGagne P; Witwicki E
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):83S-86S. PubMed ID: 2507222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
    Tjiam KH; Wagenvoort JH; van Klingeren B; Piot P; Stolz E; Michel MF
    Eur J Clin Microbiol; 1986 Oct; 5(5):498-501. PubMed ID: 3096726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of temafloxacin against pathogens causing sexually transmitted diseases.
    Segreti J
    Am J Med; 1991 Dec; 91(6A):24S-26S. PubMed ID: 1662891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogens.
    Lefèvre JC; Bauriaud R; Gaubert E; Escaffre MC; Lareng MB
    Chemotherapy; 1992; 38(5):303-7. PubMed ID: 1337506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
    Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in-vitro activity of sparfloxacin against genital pathogens.
    Perea EJ; Aznar J; Garcia-Iglesias MC; Pascual A
    J Antimicrob Chemother; 1996 May; 37 Suppl A():19-25. PubMed ID: 8737122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
    Liebowitz LD; Saunders J; Fehler G; Ballard RC; Koornhof HJ
    Antimicrob Agents Chemother; 1986 Dec; 30(6):948-50. PubMed ID: 3101590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Renaudin H; Bébéar C
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):838-41. PubMed ID: 1964899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis.
    Talbot H; Romanowski B
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2049-51. PubMed ID: 2533473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of fluoroquinolones in sexually transmitted diseases.
    Tartaglione TA; Hooton TM
    Pharmacotherapy; 1993; 13(3):189-201. PubMed ID: 8321733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antimicrobial activity of rosoxacin against Neisseria gonorrhoeae, Chlamydia trachomatis, and Ureaplasma urealyticum.
    Dobson RA; O'Connor JR; Poulin SA; Kundsin RB; Smith TF; Came PE
    Antimicrob Agents Chemother; 1980 Nov; 18(5):738-40. PubMed ID: 6778385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical effect of NY-198 (lomefloxacin) for sexually transmitted disease--bacteriological effect of U. urealyticum].
    Kawamura N; Nishizawa K; Kawashima T; Koinuma A; Ohhara K
    Kansenshogaku Zasshi; 1990 Jan; 64(1):1-11. PubMed ID: 2335746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
    Ridgway GL; Mumtaz G; Gabriel FG; Oriel JD
    Eur J Clin Microbiol; 1984 Aug; 3(4):344-6. PubMed ID: 6237903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of lomefloxacin (SC 47111 or NY-198) against Chlamydia trachomatis strains.
    Segreti J; Kessler HA; Kapell K; Trenholme GM
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):87S-88S. PubMed ID: 2791503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.
    Aldridge KE; Henderberg A; Gebbia K; Schiro DD; Janney A; Sanders CV
    Diagn Microbiol Infect Dis; 1989; 12(3):221-33. PubMed ID: 2791485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina.
    Bianchini HN; Sarachian B; Fernandez A; Paolasso R; Kaufman C; Notario R; Porven G; Ingaramo RA; Perez S; Ferrero SM
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):45S-50S. PubMed ID: 2676328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.
    Kenny GE; Hooton TM; Roberts MC; Cartwright FD; Hoyt J
    Antimicrob Agents Chemother; 1989 Jan; 33(1):103-7. PubMed ID: 2712541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates.
    Wright DN; Saxon B; Matsen JM
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):7S-11S. PubMed ID: 2791501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly specific and efficient primers for in-house multiplex PCR detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma hominis and Ureaplasma urealyticum.
    Aguilera-Arreola MG; González-Cardel AM; Tenorio AM; Curiel-Quesada E; Castro-Escarpulli G
    BMC Res Notes; 2014 Jul; 7():433. PubMed ID: 24997675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum to two new quinolones, sparfloxacin and WIN 57273.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1515-6. PubMed ID: 1929320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.